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Abstract: The aim of this study was to test the effects of two disparate isonitrogenous,
isocaloric pre-exercise feeds on deuterium-oxide (D2O) derived measures of myofibrillar protein
synthesis (myoPS) in humans. Methods: In a double-blind parallel group design, 22 resistance-trained
men aged 18 to 35 years ingested a meal (6 kcal·kg−1, 0.8 g·kg−1 carbohydrate, 0.2 g·kg−1 fat) with
0.33 g·kg−1 nonessential amino acids blend (NEAA) or whey protein (WHEY), prior to resistance
exercise (70% 1RM back-squats, 10 reps per set to failure, 25% duty cycle). Biopsies of M. vastus
lateralis were obtained pre-ingestion (PRE) and +3 h post-exercise (POST). The myofibrillar fractional
synthetic rate (myoFSR) was calculated via deuterium labelling of myofibrillar-bound alanine,
measured by gas chromatography–pyrolysis–isotope ratio mass spectrometry (GC-Pyr-IRMS). Data are
a mean percentage change (95% CI). Results: There was no discernable change in myoFSR following
NEAA (10(−5, 25) %, p = 0.235), whereas an increase in myoFSR was observed after WHEY (28 (13, 43)
%, p = 0.003). Conclusions: Measured by a D2O tracer technique, a disparate myoPS response was
observed between NEAA and WHEY. Pre-exercise ingestion of whey protein increased post-exercise
myoPS, whereas a NEAA blend did not, supporting the use of NEAA as a viable isonitrogenous
negative control.
Keywords: amino acids; deuterium oxide; humans; protein synthesis; resistance training; skeletal
muscle; whey proteins
1. Introduction
Resistance exercise increases uptake of amino acids into the muscle and stimulates muscle
protein synthesis (MPS) [1]. An increase in the extracellular concentration of essential amino acids
(EAA) [2], particularly leucine [3,4], also stimulates MPS. Thus, consumption of EAA-rich protein in
temporal proximity to resistance exercise further stimulates MPS in a dose-dependent manner [5],
whereas nonessential amino acids (NEAA) do not have any additional stimulatory effect on MPS when
co-ingested with EAA [6,7].
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To assess the effect of dietary protein feeding on MPS in a nitrogen-balanced design,
an isonitrogenous control is required [8,9]. However, according to authors’ knowledge, the effect of
protein ingestion on post-exercise MPS in humans has only been validated against non-nitrogenous
(e.g., fasted conditions or a non-caloric placebo) [5,10–12] controls, non-nitrogenous isocaloric
(e.g., carbohydrate) controls [13–15], or isonitrogenous proteins (e.g., whey, casein, and soy) [11,12,16,17],
which potentially affect MPS. In a recent ex-vivo cell-based study, we confirmed that a pre-defined
blend of NEAA had no effect on de novo protein synthesis [18]. The aim of the present study
was to investigate whether the NEAA blend could act as a viable isonitrogenous negative control,
in human feeding studies assessing MPS after resistance-exercise.
In this paper, we report data from a pilot study investigating the effect of pre-exercise NEAA
ingestion on post-exercise D2O-derived measures of myofibrillar protein synthesis (myoPS) in resistance
trained men aged 18 to 35 years. As proof-of-concept, we compared the feeding effects of NEAA
to an EAA-rich whey protein (WHEY). We hypothesized that WHEY would stimulate myoPS after
resistance exercise [5,7,10–16], whereas NEAA would not.
2. Materials and Methods
2.1. Ethical Statement
Prior to enrolling in the study, participants were informed of the risks and benefits associated
with participation before providing written informed consent. Ethical approval was granted by the
University of Limerick Education and Health Sciences Research Ethics Committee (2016_12_09 EHS,
2013_01_13 EHS), which conforms to standards set by the Declaration of Helsinki. The study was
pre-registered at https://www.clinicaltrials.gov as NCT03297151.
2.2. Participants
Eligibility criteria were: (i) men aged 18 to 35 years, (ii) six-months of resistance training experience
(>3 h·wk−1) immediately prior to starting the study, (iii) able to competently perform a 1.25 kg·kg−1
body mass one-repetition maximum (1RM) barbell back-squat, (iv) no current injury, illness, medication,
or history of chronic disease, and (v) no lactose intolerance. To assess eligibility criteria, a health screen
and 1RM test was conducted the week prior to testing.
2.3. Study Conduct
Participants reported to the laboratory each morning (06:00 to 08:00) fasted overnight (~ 10 h
post-absorptive), and refrained from any formal exercise and dietary supplement use for 3 d. Day 1
participants provided saliva and venous blood samples prior to ingesting 400 mL (100 mL·h−1) D2O
(70 atom%). Venous blood was centrifuged (1750 g for 10 min at 22 ◦C) and plasma was aliquoted
and frozen at −80 ◦C. A second saliva sample was taken 2 h after the final D2O bolus (Figure 1).
On day 2, a third saliva sample and a micro-biopsy of m.vastus lateralis (via standard protocol [19])
was taken to determine basal myofibrillar fraction synthetic rate (myoFSR) (PRE) (Figure 1). Muscle
samples were rapidly dissected free of fat and connective tissue, washed in ice-cold saline, snap frozen
in liquid N2, and stored at −80 ◦C. Thirty min after the biopsy participants consumed a fixed meal
(6 kcal·kg−1, 0.8 g·kg−1 carbohydrate, 0.2 g·kg−1 fat) with a drink containing 0.33 g·kg−1 NEAA or
whey protein (Table 1). Twenty-four participants were recruited in total and randomly allocated to
a whey protein concentrate (WPC, n = 8), whey protein hydrolysate (WPH, n = 8), or NEAA-group
(n = 8) in a double-blind parallel group design. Thirty min post-ingestion participants completed
a resistance exercise session. A second micro-biopsy of m. vastus lateralis and saliva sample was taken
3 h post-exercise (POST) (Figure 1). Two participants (n = 1 from each whey protein group) failed to
comply with the study conduct and were excluded from the final analysis.
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Figure 1. Schematic diagram of the study conduct. D2O, deuterium oxide tracer. The isonitrogenous, 
isocaloric feed was a fixed meal (6 kcal·kg−1, 0.8 g·kg−1 carbohydrate, 0.2 g·kg−1 fat) with a drink 
containing 0.33 g·kg−1 nonessential amino acids or whey protein concentrate/hydrolysate in a 
randomized double-blind parallel group design. 
2.4. Resistance Exercise 
Participants completed sets of 10 barbell back-squats to volitional exhaustion. For the back-
squat, participants fixed a loaded barbell (70% 1RM) across the shoulders on the trapezius (above the 
posterior aspect of the deltoids) and flexed hips and knees until thighs were parallel to the floor, and 
then extended hips and knees were in an upright standing position [20]. Each repetition was 
performed at a cadence of 6 s (timed by a metronome or visible timer). Three min rest was taken 
between sets (25% duty cycle). Volitional exhaustion was operationally defined as the inability to 
complete a repetition, or an observable change in the technical execution exercise increasing injury 
risk (e.g., spinal flexion, valgus collapse, asymmetry, and imbalance) [20]. To ensure compliance and 
form the resistance exercise sessions were supervised by an experienced strength and conditioning 
professional. 
2.5. Body Water Enrichment 
Pure body water was extracted through heating 100 µL of the saliva sample, before being 
condensed and transferred to an autosampler vial ready for injection into a high-temperature 
conversion elemental analyser (TC-EA) (Thermo Finnigan, Thermo Scientific, Hemel Hempstead, 
UK) connected to an isotope ratio mass spectrometer (IRMS) (Delta V Advantage, Thermo Scientific). 
To minimise the carryover between samples, each sample was injected four times, with the average 
of the last three injections used for analysis. For accuracy, a standard curve of known D2O enrichment 
was run alongside samples. 
2.6. Protein Bound Alanine Enrichment 
To measure myofibrillar alanine enrichment, 30 mg of muscle was homogenised in ice cold 
homogenisation buffer, vortexed for 10 min, and centrifuged at 13,000 g for 10 min at 4 °C before the 
supernatant was removed. The pellet was solubilized in 0.3 M NaOH before centrifugation at 13,000 
g for 10 min at 4 °C to separate the insoluble collagen fraction. The myofibrillar containing 
supernatant was subsequently collected and the proteins were precipitated by the addition of 1 M 
perchloric acid (PCA). For the plasma proteins, 100 µL of sample was precipitated using 100 µL ice 
cold ethanol and then separated through centrifugation. Protein-bound amino acids were hydrolysed 
overnight in 0.1 M HCl and Dowex H+ resin at 110 °C, before elution with 2 M NH4OH and 
evaporated to dryness. Amino acids were derivatised to their n-methoxycarbonyl methyl esters by 
resuspension in 60 µL distilled water and 32 µL methanol, before vortexing and the addition of 10 
µL pyridine and 8 µL methylchloroformate. Samples were further vortexed and extracted in 100 µL 
chloroform and the addition of a molecular sieve to remove any remaining water, before being 
transferred into a new small volume chromatography vial insert. The deuterium enrichment of 
protein-bound alanine was measured by sample injection and assessment by gas chromatography–
pyrolysis–isotope ratio mass spectrometry (GC-Pyr-IRMS, Delta V Advantage, Thermo Scientific). 
Figure 1. Schematic diagram of the study conduct. D2O, deuterium oxide tracer. The isonitrogenous,
isocaloric feed was a fixed meal (6 kcal·kg−1, 0.8 g·kg−1 carbohydrate, 0.2 g·kg−1 fat) with
a drink containing 0.33 g·kg−1 nonessential amino acids or whey protein concentrate/hydrolysate in
a randomized double-blind parallel group design.
Table 1. Amino acid composition of the whey protein and nonessential amino acid blend.
WHEY NEAA
mg·kg−1 % mg·kg1 %
Alanine 17 5 33 10
Arginine 8 2 0 0
Aspartic acid 35 11 41 12
Cysteine 8 2 0 0
Glutamic acid 56 17 120 36
Glycine 6 2 13 4
Histidine 6 2 0 0
Isoleucine 20 6 0 0
Leucine 34 10 0 0
Lysine 30 9 0 0
Methionine 7 2 0 0
Phenylalanine 10 3 0 0
Proline 19 6 53 16
Serine 17 5 45 14
Threonine 23 7 0 0
Tryptophan 7 2 0 0
Tyrosine 9 3 25 8
Valine 19 6 0 0
EAA 0.16 48 0 0
NEAA 0.17 52 0.33 100
Total 0.33 0.33
Isonitrogenous whey protein (WHEY) and nonessential amino acid (NEAA) blend dose was scaled to a body mass
(kg) concentrate and hydrolysate amino acid composition was equivalent. Data are mg·kg−1 body mass and %
total mass.
2.4. Resistance Exercise
Participants co pleted sets of 10 barbell back-squats to volitional exhaustion. For the back-squat,
participants fixed a loaded barbell (70% 1RM) across the shoulders on the trapezius (above the posterior
aspect of the deltoids) and flexed hips and knees until thighs were parallel to the floor, and then
extended hips and knees were in an upright standing position [20]. Each repetition was performed at
a cadence of 6 s (timed by a metronome or visible timer). Three min rest was taken between sets (25%
duty cycle). Volitional exhaustion was operationally defined as the inability to complete a repetition,
or an observable change in the technical execution exercise increasing injury risk (e.g., spinal flexion,
valgus collapse, asymmetry, and imbalance) [20]. To ensure compliance and form the resistance exercise
sessions were supervised by an experienced strength and conditioning professional.
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2.5. Body Water Enrichment
Pure body water was extracted through heating 100µL of the saliva sample, before being condensed
and transferred to an autosampler vial ready for injection into a high-temperature conversion elemental
analyser (TC-EA) (Thermo Finnigan, Thermo Scientific, Hemel Hempstead, UK) connected to an isotope
ratio mass spectrometer (IRMS) (Delta V Advantage, Thermo Scientific). To minimise the carryover
between samples, each sample was injected four times, with the average of the last three injections used
for analysis. For accuracy, a standard curve of known D2O enrichment was run alongside samples.
2.6. Protein Bound Alanine Enrichment
To measure myofibrillar alanine enrichment, 30 mg of muscle was homogenised in ice cold
homogenisation buffer, vortexed for 10 min, and centrifuged at 13,000 g for 10 min at 4 ◦C before the
supernatant was removed. The pellet was solubilized in 0.3 M NaOH before centrifugation at 13,000 g
for 10 min at 4 ◦C to separate the insoluble collagen fraction. The myofibrillar containing supernatant
was subsequently collected and the proteins were precipitated by the addition of 1 M perchloric acid
(PCA). For the plasma proteins, 100 µL of sample was precipitated using 100 µL ice cold ethanol
and then separated through centrifugation. Protein-bound amino acids were hydrolysed overnight
in 0.1 M HCl and Dowex H+ resin at 110 ◦C, before elution with 2 M NH4OH and evaporated to
dryness. Amino acids were derivatised to their n-methoxycarbonyl methyl esters by resuspension
in 60 µL distilled water and 32 µL methanol, before vortexing and the addition of 10 µL pyridine
and 8 µL methylchloroformate. Samples were further vortexed and extracted in 100 µL chloroform
and the addition of a molecular sieve to remove any remaining water, before being transferred into
a new small volume chromatography vial insert. The deuterium enrichment of protein-bound alanine
was measured by sample injection and assessment by gas chromatography–pyrolysis–isotope ratio
mass spectrometry (GC-Pyr-IRMS, Delta V Advantage, Thermo Scientific). Samples were injected in
triplicate, alongside a standard curve of known L-alanine-2,3,3,3-d4 enrichment.
2.7. Calculation of Fractional Synthetic Rate
MyoFSR was calculated from incorporation of deuterium-labelled alanine into the myofibrillar
protein using body water as a surrogate for precursor enrichment (corrected for the mean number of
deuterium moieties incorporated per alanine (3.7) and the total number of hydrogen atoms within the
alanine derivative (11)) [21–23]. The equation used is shown below.
myoFSR = − ln

1−
[
APEAla
APEp
]
t
 (1)
where APEala is deuterium enrichment of protein-bound alanine, APEp is mean precursor enrichment
over the study, and t is the time between biopsies.
2.8. Postprandial Aminoacidemia
In a separate study, eight participants (age = 25 (5) y, stature = 1.8 (0.1) m, body mass = 82 (12) kg,
mean (SD)) were recruited to a double-blind crossover study to assess postprandial aminoacidemia
response following isonitrogenous ingestion of the NEAA blend, whey protein concentrate (WPC),
and whey protein hydrolysate (WPH) (0.33 g·kg−1 body mass). In this study, participants reported
to the lab on three separate occasions, at least 4 d apart, (06:00 to 08:00) fasted overnight (~10 h
post-absorptive), refrained from any formal exercise, and nutritional supplement use 3 d prior to
testing. A cannula was inserted into the antecubital vein and a blood sample was collected in EDTA
s-monovette® tubes (PRE). Participants then ingested 0.33 g·kg−1 of each test drink (Table 1) and
postprandial blood samples were collected at 30 min intervals, up to 180 min. Participants remained in
a seated position throughout the sampling period. Blood was centrifuged (e.g., 514× g, 4 ◦C for 10 min,
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Eppendorf 5417R, Eppendorf AG, Hamburg, Germany) plasma was aliquoted and stored at −80 ◦C
for analysis.
Plasma amino acid profile was measured (via a standard protocol [24]), using the Agilent 1200
RPUPLC system (Agilent Technologies, Santa Clara, CA, USA) equipped with an Agilent 1260 binary
pump and a G1367C automated liquid handling system. Chemstation software (Agilent Technologies
Inc.) was used for data acquisition. Separation of amino acids was carried out using a C18 ZORBAX
rapid resolution column (4.6 × 50 mm, 1.8 µm, Agilent Technologies Inc.) thermo-stated at 40 ◦C.
Quantitative analysis was performed by the external standard method, using the Agilent amino acid
standard (Agilent Technologies Inc.). Standards were measured in both not spiked and spiked pool
plasma and recoveries were calculated. Total area under the curve (AUC) was calculated using the
trapezoidal rule.
2.9. Statistical Analysis
Descriptive statistics are mean (SD). Change (∆) and percent change (∆%) values (PRE to POST)
are reported mean (95% CI). For statistical analysis, normality and homogeneity were confirmed prior
to performing parametric statistical tests. Mixed-model ANOVA was used to assess group × time
interaction. Independent t-tests were used to assess difference between groups. Paired t-tests were used
to assess a difference within the groups. The critical significance level was α = 0.05. A false-discovery
rate correction was used to adjust for a familywise error [25]. Sample size estimates (1 − β = 0.8)
were calculated from previously published data [22]. The magnitude of the change was examined by
effect size calculation (Cohen’s d [26]). In areas where there was no difference between the WPC and
WPH groups (data provided Appendix A), data were pooled into a single WHEY-group (n = 14) for
comparative evaluation against the NEAA (n = 8). Statistical tests were performed in RStudio (1.1.383).
3. Results
3.1. Participants and Resistance Training Performance
No differences were observed between NEAA and WHEY groups for age, stature, body mass,
1RM strength, resistance training experience, or resistance training performance (Table 2).
Table 2. Baseline characteristics.
NEAA (n = 8) WHEY (n = 14) p-Value
Age (y) 23 (5) 23 (4) 0.666
Stature (m) 1.77 (0.04) 1.82 (0.07) 0.120
Body mass (kg) 77 (17) 81 (10) 0.455
1RM (kg·kg−1) 1.5 (0.3) 1.5 (0.2) 0.985
RET experience (y) 2.6 (1.5) 2.4 (1.1) 0.602
RET performance (sets) 8.7 (1.5) 7.6 (1.8) 0.287
Data are mean (SD). 1RM, barbell back-squat one repetition maximum per kg body mass. RET,
resistance exercise training.
3.2. Aminoacidemia
3.2.1. Plasma Amino Acid Concentration
Plasma amino acid concentration AUC was 16 (11) % higher in the WHEY vs. NEAA-group
(p = 0.003). There was a group × time interaction (p < 0.001). Amino acid concentration was higher
in the WHEY-group vs. NEAA at 30, 60, and 90 min (p < 0.012). Postprandial hyperaminoacidemia
was observed up to 60 min in the NEAA-group (p < 0.034) and up to 150 min in the WHEY-group
(p < 0.004) (Figure 2A).
Nutrients 2019, 11, 1657 6 of 11
Figure 2. Postprandial plasma amino acid (AA) (Panel A), essential amino acid (EAA) (Panel B),
leucine (Panel C), and nonessential amino acid (NEAA) concentration (Panel D) following isonitrogenous
ingestion of a NEAA blend (open, n = 8) or whey protein (grey, n = 14). Data are mean +/− SD.
† significant difference between groups. * Significant difference from baseline (0 min) (p < 0.05).
3.2.2. Plasma Essential Amino Acid Concentration
EAA AUC was 76 (17) % higher in the WHEY vs. NEAA-group (p < 0.001). A group × time
interaction was observed (p < 0.001). Postprandial EAA concentration was higher in the WHEY-group
vs. NEAA-group at all time-points (p < 0.001). No increase in EAA was observed in the NEAA-group
(p > 0.255), whereas postprandial increases were observed up to 180 min in the WHEY-group (p < 0.005)
(Figure 2B).
3.2.3. Plasma Leucine Concentration
Plasma leucine AUC was 124 (28) % higher in the WHEY vs. NEAA-group (p < 0.001). A group
× time interaction was observed (p < 0.001). Postprandial leucine concentration was higher in the
WHEY-group vs. NEAA-group at all time-points (p < 0.001). In the NEAA group, leucine concentration
decreased below PRE after 90 min (p < 0.001), whereas postprandial increases in leucine were observed
up to 180 min in the WHEY-group (p < 0.002) (Figure 2C).
3.2.4. Plasma Nonessential Amino Acid Concentration
Plasma NEAA AUC was 19 (10) % higher in the NEAA vs. WHEY-group (p < 0.001). A group ×
time interaction was observed (p < 0.001). Total NEAA concentration was higher in the NEAA-group
vs. WHEY-group at all time-points (p < 0.05). Postprandial increases were observed up to 180 min in
the NEAA-group (p < 0.034) and up to 120 min in the WHEY-group (p < 0.004) (Figure 2D).
3.3. Body Water Enrichment
Body D2O water enrichment increased 0.49 (0.06) % PRE (WHEY 0.49 (0.05) % vs. NEAA 0.51
(0.08) %, p = 0.456) and was stable through the 5 h study period (0.49 (0.06) % POST, p = 0.772).
3.4. Myofibrillar Protein Synthesis
There was no myoFSR difference between groups PRE (WHEY 0.065 (0.008) %·h−1 vs. NEAA
0.066 (0.009) %·h−1, p = 0.717). Group differences were observed PRE to POST, but failed to reach the
Nutrients 2019, 11, 1657 7 of 11
critical significance level (∆ = 0.011 (0.006, 0.016) %·h−1, d = 0.7, p = 0.059). There was no myoFSR
change in the NEAA-group (POST = 0.072 (0.010) %·h−1, ∆ = 0.006 (-0.003, 0.014) %·h−1, ∆% = 10 (–5,
25) %, d = 0.4, p = 0.235), whereas a myoFSR increase was observed in the WHEY-group (POST = 0.082
(0.016) %·h−1, ∆ = 0.017 (0.008, 0.026) %·h−1, ∆% = 28 (13, 43) %, d = 0.9, p = 0.003) (Figure 3).
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of mTOR, p70S6k, or 4e-BP1 was observed in the NEAA condition. Conversely, increases in de novo 
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Figure 3. Myofibrillar fractional synthetic rate (FSR, %·h−1) pre-ingestion (PRE) and 3 h post-exercise
(POST). Isonitrogenous whey protein group (WHEY, n = 14, open boxes) and nonessential amino
acid group (NEAA, n = 8, grey boxes). Boxplot shows median (line) and interquartile range (box),
whiskers represent the maximum and minimum values. * Significant difference vs. PRE; NS,
not-significantly different vs. PRE (p < 0.05). Group × time interaction (p = 0.059).
4. Discussion
In this paper, we report data from a pilot study investigating the effects of two isonitrogenous,
isocaloric pre-exercise feeds on post-exercise, D2O-derived, measures of myoPS in resistance trained
men aged 18 to 35 years. One feed contained 0.33 g·kg−1 EAA blend, while the other co tained
WHEY. In line with previous reports, we observed a 2 rease in myoPS with WHEY [5,7,10–16],
and report no significa t hange in post-exercise myoPS after ingestion of NEA . We and others have
previously employed the D2O tracer technique assess basal, postprandial, and post-exercise myoFSR
in humans [21–23], but this is the first study to use the D2O method to evaluate the combined effects of
feeding and resistance exercise on acute (<5 h post-exercise) measures of myoPS.
The amino acid profile of the NEAA blend, used in the present study, was modelled on the
NEAA composition of milk protein (Table 1). Postprandial aminoacidemia response following WHEY
and NEAA blend ingestion was confirmed, at rest, in a separate study (Figure 2). In this study,
hypera inoacidemia as observed in both gr ups (NEAA + 0.6 mmol·L−1 ~ 40%, WHEY + 1.6
mmol·L−1 ~ 70%), which peaked 60 minutes post-ingestion. However, following WHEY ing stion,
there was a robust increase in the plasma concentration of the key nutrient regulators of myoPS
(i.e., EAA (+1.1 mmol ~ 75%) and leucine (+0.23 mmol ~ 190%)). We conducted a preliminary
evaluation of bioactivity of the NEAA blend in a cell-based study, where the myotube culture was
conditioned with participants’ postprandial serum [18]. No change in de novo protein synthesis,
phosphorylation of mTOR, p70S6k, or 4e-BP1 was observed in the NEAA condition. Conversely,
increases in de novo protein synthesis and anabolic signaling were observed after WHEY [18].
In humans, NEAA do not appear to have any additional stimulatory effect on post-exercise MPS
when co-ingested with EAA [6,7]. However, to our knowledge, the independent effect of NEAA
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ingestion (i.e., without EAA) on post-exercise myoPS has not been verified. In the present human study,
the basal (0.06 (0.01) %·h−1) and postprandial/postexercise myoFSR (0.08 (0.02) %·h−1) was comparable
to other human studies employing similar exercise/feeding interventions [5,23,27,28]. Thus, the finding
that pre-exercise ingestion of NEAA evoked no increase post-exercise myoPS, supports the passive
role for NEAA in the regulation of myoPS/MPS [6,7,18], and promotes the potential role of the NEAA
blend as an isonitrogenous negative control for the measurement of myoPS in protein feeding studies.
Comparative evaluation of dietary protein (or derivative) ingestion against an isonitrogenous, isocaloric
control in a nitrogen-balanced design, provides a more accurate and comprehensive appraisal of
the potential bio-efficacy of proprietary proteins or protein derivatives, promoted for supplemental
use in clinical or athletic populations. Therefore, as proof-of-concept, we compared the effect of the
NEAA (negative control) to an EAA-rich whey-protein (positive control). The myoFSR increase after
WHEY, confirms the sensitivity of D2O-derived measures of myoPS to detect an acute protein feeding
response (<5 h), and further supports the efficacy of the NEAA blend as a viable negative control for
the measurement of myoPS in protein feeding studies [11,12,16].
Based on our knowledge, this is the first study to report acute stimulation of post-exercise
D2O-derived myoPS following ingestion of a reputable dietary protein supplement, known to enhance
post-exercise myoPS [5,7,10–16]. Recently, it has been discussed whether interventions that increase
short-term lab-based measures of myoPS/MPS can be used to enhance muscle remodeling/hypertrophy
over a longer period of time [29,30]. One advantage of the D2O tracer technique is the relatively slow
decay of the precursor pool (i.e., body water) [22], which allows continuous measurement of free-living
myoPS to be made over days [21] or weeks [21,31]. Therefore, future research can employ the D2O
tracer method to assess the effect of supplemental dietary protein on longer-term measures of myoPS.
5. Conclusions
In conclusion, we demonstrate that pre-exercise ingestion of two disparate isonitrogenous,
isocaloric feeds, containing NEAA and WHEY, differentially effect post-exercise myoPS. Pre-exercise
ingestion of EAA-rich WHEY increased post-exercise D2O-derived measures of myoPS, while ingestion
of an isonitrogenous NEAA blend (0.33 g·kg−1) did not appear to stimulate myoPS. The findings from
the present study supports the passive role for NEAA in the regulation of myoPS, and promotes the
use of NEAA as a viable isonitrogenous negative control in human feeding studies investigating the
role of dietary protein on myoPS.
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Appendix A
NEAA (n = 8) WPC (n = 7) WPH (n = 7)
myoFSR PRE (%·h−1) 0.066 (0.008) 0.068 (0.006) 0.063 (0.008)
myoFSR POST (%·h−1) 0.072 (0.010) 0.084 (0.017) 0.079 (0.016)
% change 10 (−5, 25) 27 (2, 51) * 30 (5, 55) *
Myofibrillar protein fractional synthetic rate (myoFSR) data pre-ingestion (PRE) and 3 h post-exercise
(POST). NEAA, nonessential amino acid group. WPC, whey protein concentrate group. WPH,
whey protein hydrolysate group. Data are mean (SD) or (95% CI). p = 0.377 (3 × 2 ANOVA). *
Significant difference vs. PRE (p < 0.05) (paired t-test).
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